Zobrazeno 1 - 10
of 84
pro vyhledávání: '"U Wandl"'
Publikováno v:
Medizinische Gutachten ISBN: 9783662434246
Medizinische Gutachten ISBN: 9783540723516
Medizinische Gutachten ISBN: 9783540723516
In diesem Kapitel werden die Folgen von Tumorerkrankungen und die damit einhergehenden Funktionseinschrankungen behandelt. Dabei steht der Einfluss, den die Erkrankung zum Zeitpunkt der Begutachtung auf das Leistungsvermogen des Patienten hat, im Mit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc9c2b4f4940ccc3be56d6934ce0cb3
https://doi.org/10.1007/978-3-662-43425-3_20
https://doi.org/10.1007/978-3-662-43425-3_20
Publikováno v:
Versicherungsmedizin. 65(2)
Even though 85 percent of those who have been severely injured in an accident in Germany survive, complex and serious long-term consequences are still a major problem not only for health and care insurance providers but also for the accident victims
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::afde95960f53cc8bf828bedda1d02418
https://pubmed.ncbi.nlm.nih.gov/23926704
https://pubmed.ncbi.nlm.nih.gov/23926704
Publikováno v:
Versicherungsmedizin. 63(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d0f261a1fadc8ffb1e7aa94176a38591
https://pubmed.ncbi.nlm.nih.gov/21488382
https://pubmed.ncbi.nlm.nih.gov/21488382
Publikováno v:
Medizinische Gutachten ISBN: 9783540723516
Medizinische Gutachten ISBN: 9783662434246
Medizinische Gutachten ISBN: 9783662434246
In diesem Kapitel werden wichtige Rechtsbegriffe erlautert, die fur die Erstattung von Gutachten in den unterschiedlichen Rechtsgebieten der sozialen wie der privaten Versicherungszweige wichtig sind und deren Bedeutung dem Sachverstandigen bei der E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6246d558a8a6c58c215637212f22dd40
https://doi.org/10.1007/978-3-540-72352-3_2
https://doi.org/10.1007/978-3-540-72352-3_2
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 64(8)
Disability and loss of earning capacity cost private businesses and the social insurance providers a lot of money in Germany. It is particularly difficult for persons with impaired performance capacity to return to working life. To ensure that the av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::97e4e5399a0e3546d909bd20a0d25b8e
https://pubmed.ncbi.nlm.nih.gov/17987999
https://pubmed.ncbi.nlm.nih.gov/17987999
Publikováno v:
Versicherungsmedizin. 59(1)
A policyholder claiming an annuity benefit on the grounds that, he is no longer able to pursue his occupation must meet certain obligations vis-à-vis the insurer, e.g. duty to mitigate the loss, duty to cooperate with the insurer. These obligations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c147297b95eb9cea5019ea04fc824b3
https://pubmed.ncbi.nlm.nih.gov/17424985
https://pubmed.ncbi.nlm.nih.gov/17424985
Publikováno v:
Versicherungsmedizin. 56(2)
Thanks to its huge portfolio of life reinsurance treaties, Swiss Reinsurance Company (Swiss Re) can carry out extensive medical statistics studies. In Swiss Re's "Leben-Tarifierungsstudie 2000", a variety of increased mortality risks were investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e60660096fb2ae6f1dfee17184bc9cf2
https://pubmed.ncbi.nlm.nih.gov/15224506
https://pubmed.ncbi.nlm.nih.gov/15224506
Autor:
S, Hinterstrasser-Irmer, U, Wandl
Publikováno v:
Versicherungsmedizin. 51(4)
ReIntra is a medical/occupational counselling and reintegration service launched in 1997 with the aim of supporting seriously injured accident victims along their path towards, hopefully, social and professional rehabilitation. We have analysed 109 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a2f21956b2e483aac73c45c8a13a0f7
https://pubmed.ncbi.nlm.nih.gov/10630089
https://pubmed.ncbi.nlm.nih.gov/10630089
Publikováno v:
Leukemia. 5(6)
The breakpoint localization was analyzed in 61 patients with Philadelphia chromosome (Ph) positive chronic myelogenous leukemia to compare the breakpoint localization and clinical course. All patients were treated with interferon alfa (IFN alpha) or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b720cf1183a8ef475c160f6553ccb08
https://pubmed.ncbi.nlm.nih.gov/2056769
https://pubmed.ncbi.nlm.nih.gov/2056769
Publikováno v:
Acta oncologica (Stockholm, Sweden). 30(5)
Fourteen patients with metastatic carcinoid tumors were treated with recombinant interferon alpha-2b at a dosage of 3-4 x 10(6) IU s.c. daily or every second day. No objective tumor regression was observed. Six out of 8 patients with carcinoids of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c17586664430359580b37aa2c9b8101d
https://pubmed.ncbi.nlm.nih.gov/1892678
https://pubmed.ncbi.nlm.nih.gov/1892678